Vimentin expression is not associated with poor prognosis in breast cancer

International Journal of Cancer

Volumn 67, Issue 3, 1996, Pages 353-356

  Seshadri, Ram ^a,c   Raymond, Wendy A ^a   Leong, Anthony S Y ^b   Horsfall, David J ^a   McCaul, Kieran ^b  

^a FLINDERS UNIVERSITY   (Australia)

^b South Australian Health Commission   (Australia)

^c FLINDERS MEDICAL CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANTIGEN EXPRESSION; ARTICLE; BREAST BIOPSY; BREAST CANCER; CANCER MORTALITY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MASTECTOMY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DETERMINATION; RECURRENCE RISK;

ANTIBODIES, MONOCLONAL; BREAST NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; PARAFFIN EMBEDDING; PROGNOSIS; VIMENTIN;

EID: 0029809006     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19960729)67:3<353::AID-IJC8>3.0.CO;2-Q     Document Type: Article

References (26)

1. AZUMI, N. and BATTIFORA, H., The distribution of vimentin and keratin in epithelial and non-epithelial neoplasms. Amer. J. clin. Pathol., 88, 286-296 (1987).
2. BLOOM, H.J. and RICHARDSON, W.W., Histological grading and prognosis in breast cancer. Brit. J. Cancer, 11, 359-357 (1957).
3. CATTORETTI, G., ANDREOLA, S., CLEMENTS, C., D'AMATO, L. and RILKE, F., Vimentin and TP53 expression on epidermal growth factor receptor-positive, oestrogen receptor-negative breast carcinomas. Brit. J. Cancer, 57, 353-357 (1988).
4. COX, D.R. and HINKLEY, D.V., Theoretical statistics, pp. 314-317, Chapman and Hall, London (1974).
5. DOMOGALA, W., LASOTA, J., BARTKOWIAK, J., WEBER, K. and OSBORN, M., Vimentin is preferentially expressed in human breast carcinomas with low estrogen receptor and high Ki-67 growth fraction. Amer. J. Pathol., 136, 219-227 (1990).
6. DOMOGALA, W., MARKIEWSKI, M., KUBIAK, R., BARTKOWIAK, J. and OSBORN, M., Immunohistochemical profile of invasive lobular carcinoma of the breast: predominantly vimentin and TP53 protein negative, cathepsin D and oestrogen receptor positive. Virchows Arch. A. Pathol. Anat. Histopathol., 423, 497-502 (1993).
7. ELLIS, I.O., BELL, J., RONNAN, J.E., ELSTON, C.W. and BLAMEY, R., Immunocytochemical investigation of intermediate filament proteins and epithelial membrane antigen in spindle cell tumours of the breast. J. Pathol., 154, 157-165 (1988).
8. GAGLIA, P., BERNARDI, A., VENESIO, T., CALDAROLA, B., LAURO, D. and CAPPA, A.P., Cell proliferation of breast cancer evaluated by anti-BrdU and anti-Ki-67 antibodies: its prognostic value on short-term recurrence. Europ. J. Cancer, 29A, 1501-1502 (1993).
9. GOULD, V.E., Histiogenesis and differentiation: a re-evaluation of these concepts as criteria for the classification of tumors. Hum. Pathol., 17, 212-214 (1986).
10. GOULD, V.E., KOUKOULIS, G.K., JANSSON, D.S., NAGLE, R.B., FRANKE, W.W. and MOLL, R., Co-expression patterns of vimentin and glial filament protein with cytokeratins in the normal, hyperplastic, and neoplastic breast. Amer. J. Pathol., 137, 1143-1155 (1990).
11. HORSFALL, D.J., TILLEY, W.D., ORELL, S.R., MARSHALL, V.R. and CANT, E.L.M., Relationship between ploidy and steroid hormone receptors in primary breast cancer. Brit. J. Cancer, 53, 23-28 (1986).
12. KAPLAN, E.L. and MEIER, P., Nonparametric estimation from incomplete observasions. J. amer. Stat. Assoc., 53, 457-481 (1958).
13. LEADER, M., COLLINS, M., PATEL, J. and HENRY, K., Vimentin: an evaluation of its role as a tumour marker. Histopathology, 11, 63-72 (1987).
14. LEONO, A.S.-Y., Applied immunohistochemistry for the surgical pathologist, pp. 86-87, Little, Brown, Boston (1993).
15. LEONO, A.S.-Y. and MILIOS, J., An assessment of the efficacy of the microwave antigen-retrieval procedure on a range of tissue antigens. Appl. Immunohistochemistry, 1, 267-274 (1993).
16. OSBORN, M. and WEBER, K., Tumour diagnosis by intermediate filament typing: a novel tool for surgical pathology. Lab. Invest., 48, 372-394 (1983).
17. OSBORNE, C.K., Prognostic factors for breast cancer: have they met their promise? Editorial. J. Clin. Oncol., 10, 679-682 (1992).
18. RAYMOND, W. and LEONG, A.S.-Y., Vimentin: a new prognostic parameter in breast carcinoma? J. Pathol., 158, 107-114 (1989).
19. ROSEN, P.P., LESSER, M.L., ARROYA, C.D., CRANOR, M., BORGEN, P. and NORTON, L., TP53 in node-negative breast carcinoma: an immunohistochemical study of epidemiologic risk factors, histologic features, and prognosis. J. Clin. Oncol. 13, 821-830 (1995).
20. RUSSO, A., BAZAN, V., MORELLO, V., TRALONGO, V., NAGAR, C., NUARA, R., DARDONI, G., BAZAN, P. and TOMASINO, R.M., Vimentin expression, proliferating cell nuclear antigen and flow cytometric factors. Prognostic role in breast cancer. Anal. quant. Cytol. Histol., 16, 365-374 (1994).
21. SESHADRI, R., FIRGAIRA, F., HORSFALL, D.J., MCCAUL, K., SETLUR, V. and KITCHEN, P., Clinical significance of HER-2/neu oncogene amplification in primary breast cancer. J. Clin. Oncol., 11, 1936-1942 (1993).
22. SESHADRI, R., LEONG, A.S.-Y., MCCAUL, K., FIRGAIRA, F., SETLUR, V. and HORSFALL, D.J., The relationship between p53 gene abnormalities and other tumour characteristics in breast cancer prognosis. Int. J. Cancer, 69, 135-141.
23. SOMMERS, C.L., BYERS, S.W., THOMPSON, E.W., TORRI, J.A. and GELMANN, E.P., Differentiation state and invasiveness of human breast cancer cell lines. Breast Cancer Res. Treat., 31, 325-335 (1994).
24. STOVER, D.M., CAREY, I., GARZON, R.J. and ZEHNER, Z.E., A negative regulatory factor is missing in a human metastatic breast cancer cell line. Cancer Res., 54, 3092-3095 (1994).
25. TAYLOR, C.R., SHI, S.-R., CHAIWUN, B., YOUNG, L., IMAM, S.A. and COTÉ, R.J., Strategies for improving the immunochemical staining of various intranuclear prognostic markers in formalin-paraffin sections: androgen receptor, estrogen receptor, progesterone receptor, TP53 protein, proliferating cell nuclear antigen, and Ki-67 antigen revealed by antigen retrieval techniques. Hum. Pathol., 25, 263-270 (1994).
26. THOMPSON, E.W., TORRI, J., SABOL, C.L., BYERS, S., VALVERIUS, E.M., MARTIN, G.R., LIPPMAN, M.E., STAMPFER, M.R. and DICKSON, R.B., Oncogene induced basement membrane invasiveness in human mammary epithelial cells. Clin. exp. Metastasis, 12, 181-194 (1994).